9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

Estimated reading time: < 1 min

Condition: Pleural Mesothelioma

Estimated Enrollment: 20

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: Has Results

Outcome Measures: Clinical Response Rate (PR+CR),  Safety of IMC-A12 in Patients With Mesothelioma,  Duration of Overall Response, Progression Free Survival (PFS)

Interventions: IMC-A12,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: August 13, 2016

Completion Date: February 24, 2017

Last  Posted Date: April 10, 2018

Location: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Website Link: https://ClinicalTrials.gov/show/NCT01160458

Was this article helpful?
Dislike 0